Table 1 Characteristics of the included studies.
From: Treatments of depressive symptoms in cancer patients: A systematic review and network meta-analysis
Characteristics | % (No) non-pharmacological interventions of studies (n = 85) | % (No) pharmacological interventions of studies (n = 10) |
|---|---|---|
Mean age of participants (years) | ||
<55 | 48.24 (41) | 50 (5) |
55–65 | 40.00 (34) | 40 (4) |
>65 | 9.41 (8) | 10 (1) |
Not reported | 2.35 (2) | 0 |
Women (%): | ||
0–49 | 20.00 (17) | 10 (1) |
50–100 | 80.00 (68) | 90 (9) |
Cancer type | ||
Breast cancer | 43.53 (37) | 30 (3) |
No Breast cancer | 52.94 (45) | 60 (6) |
Not reported | 3.53 (3) | 10 (1) |
Duration of study intervention (weeks): | ||
<6 | 11.76 (10) | 30 (3) |
6–12 | 58.82 (50) | 70 (7) |
>12 | 25.88 (22) | 0 |
Not reported | 3.54 (3) | 0 |
Samplesize | ||
<30 | 0 | 10 (1) |
30–100 | 34.12 (29) | 70 (7) |
>100 | 65.88 (56) | 20 (2) |
Measurement tool for depression: | ||
Hospital Anxiety and Depression Scale (HADS) | 44.71 (38) | 30 (3) |
Center for Epidemiologic Studies Depression Scale (CES-D) | 12.94 (11) | 20 (2) |
Patient Health Questionnaire (PHQ)# | 12.94 (11) | 0 |
Beck Depression Inventory score (BDI) | 8.24 (7) | 0 |
Hamilton Depression Scale (HAMD) | 5.88 (5) | 20 (2) |
Other | 15.29 (13)* | 30 (3)** |
